Skip to main content
Clinical Trials/JPRN-UMIN000011847
JPRN-UMIN000011847Recruiting未知

Evaluation of the anticoagulant effect in Teneligliption in type 2 diabetic patients - Evaluation of the anticoagulant effect in Teneligliption in type 2 diabetic patients

Saitama Medical University Hospital0 sites10 target enrollmentStarted: October 1, 2013Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Recruiting
Enrollment
10

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
20years-old to ot applicable (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • "1)Type I diabetes, the diabetes which arose according to the obstacle of the pancreas, or secondary diabetes patients (Cushing syndrome, tip hypertrophia, etc.) "2)Patient who corresponds to contraindications with the package leaflet of Teneligliptin "3)Patient with an excessive habitual drinking 4)Pregnant and breast-feeding "5)Patients judged by the research responsibility (assignment) doctor to be ineligible for some other reason

Investigators

Similar Trials